BioAge Labs (BIOA) Long-Term Investments (2023 - 2026)

BioAge Labs has disclosed Long-Term Investments across 4 years of filings, most recently posting $100000.0 for Q2 2026.

• In Q2 2026, Long-Term Investments changed 0.0% year-over-year to $100000.0; the TTM figure through Jun 2026 stood at $100000.0 (changed 0.0% YoY), while the FY2025 annual figure was $100000.0, changed 0.0% from the prior year.
• Long-Term Investments came in at $100000.0 for Q2 2026 at BioAge Labs, roughly flat from $100000.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $100000.0 in Q4 2023 to a low of $100000.0 in Q4 2023.
• Average Long-Term Investments over 4 years is $100000.0, with a median of $100000.0 recorded in 2023.
• The largest YoY upside for Long-Term Investments was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
• Over 4 years, Long-Term Investments stood at $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $100000.0 in Q2 2026, $100000.0 in Q1 2026, and $100000.0 in Q4 2025.